ey0016.4-5 | New Therapeutic Options | ESPEYB16
L Lazar , S Levy , T Oron , J Meyerovitch , L de Vries , S Shalitin , A Tenenbaum , M Phillip , Y. Lebenthal
ey0020.6-10 | New Concerns | ESPEYB20
A Ben Simon , A Brener , A Segev-Becker , M Yackobovitch-Gavan , A Uretzky , A Schachter Davidov , A Alaev , A Oren , O Eyal , N Weintrob , Y Lebenthal
ey0015.9-3 | Late consequences of tumour therapy: prevention and monitoring | ESPEYB15
S Elitzur , R Houri-Shtrecher , M Yackobovitz-Gavan , G Avrahami , S Barzilai , G Gilad , Y Lebenthal , M Phillip , B Stark , I Yaniv , S Shalitin
ey0016.2-10 | Gestational Diabetes Mellitus: Neonatal and Long-term Consequences | ESPEYB16
WL Jr Lowe , DM Scholtens , LP Lowe , A Kuang , M Nodzenski , O Talbot , PM Catalano , B Linder , WJ Brickman , P Clayton , C Deerochanawong , J Hamilton , JL Josefson , M Lashley , JM Lawrence , Y Lebenthal , R Ma , M Maresh , D McCance , WH Tam , DA Sacks , AR Dyer , BE Metzger , Follow-up Study Cooperative Research Group HAPO